The aberrant expression of PD-L1 in different types of cancers along with mislocalization of it in the nucleus, which promotes drug resistance, indicating poor prognosis for cancer in patients given chemotherapy, prompted us to detect nuclear PD-L1 (nPD-L1) expression in CTCs in the present study. This evidence concerns the gene CD274 and cancer.